Inito has raised $29 million in new funding to invest in and develop AI-engineered antibodies that will help it offer new types of tests and improve the accuracy of existing ones.

Posted inNews

Inito has raised $29 million in new funding to invest in and develop AI-engineered antibodies that will help it offer new types of tests and improve the accuracy of existing ones.
This is an exciting development for at-home health testing! It’s impressive to see how AI is being utilized to enhance fertility solutions. Looking forward to seeing how Inito progresses with this innovative approach.
Absolutely! The integration of AI in creating antibodies could really revolutionize not just fertility testing, but a wide range of health diagnostics. Itβs fascinating to think about the potential for more personalized and accurate at-home tests in the near future.